possible revenue ........
Including both US and EU, I figure $50m-$100m.
Steroids are also used routinely in GVHD prevention, which is double the market, and off-label use for this seems immediately likely. Also the drug would be used for a long duration, as it's a chronic conidtion.
"....on the biotech battle-field, you need some élan...."
Market Data 
Markets 
AI
